Results 231 to 240 of about 14,968,121 (261)

Intelligent routing for human activity recognition in wireless body area networks. [PDF]

Sci Rep
Elmosallamy ES, Soliman MF.
europepmc   +1 more source

Mutant p53R273H disrupts PDPK1 homodimerization and contributes to PDPK1 activation

Molecular Oncology, EarlyView.
How mutant p53R273H drives AKT signaling is unclear. We show that p53R273H, but not wild‐type, directly binds PDPK1 via a mutation‐dependent conformational change. This interaction disrupts inhibitory PDPK1 homodimerization and enhances AKT phosphorylation.
Mei Chee Lim, Alvin Kunyao Guo, Yoko Itahana, Srinivasaraghavan Kannan, Valerie Goh, Mingmin Ong, Terina Yan Wen Tay, Weiying Ye, Sabhashina Radha Krishnan, Jun Nishiyama, Chandra S Verma, Koji Itahana   +11 more
wiley   +1 more source

A tiny inertial transformer for human activity recognition via multimodal knowledge distillation and explainable AI. [PDF]

Sci Rep
Lamaakal I, Yahyati C, Maleh Y, El Makkaoui K, Ouahbi I, El-Latif AAA, Zomorodi M, El-Rahiem BA.   +7 more
europepmc   +1 more source

Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer

Molecular Oncology, EarlyView.
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba, Mark Shacker, Timothy P. Fleming, Michael A. Smith, Ross M. Bremner, Narendra V. Sankpal   +5 more
wiley   +1 more source

Optimizing Sensor and Data Selection on Lower Limbs via Deep Learning for Real-Time Human Activity Recognition. [PDF]

IEEE Trans Hum Mach Syst
You Z, Ratnakumar N, Shen B, Su H, Zhou X.   +4 more
europepmc   +1 more source

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

Molecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David, Arthur Karaulic, Audrey Bennetot, Clémence Fournier, Quentin Odet, Arthur Gouraud, Isabelle Bourget, Cédric Gaggioli, Sandy Giuliano, Frédéric Luciano, Olivier Léger, Zaki Sellam, Gilles Pagès   +12 more
wiley   +1 more source

Generalizing location-centric variations to enhance contactless human activity recognition. [PDF]

Front Comput Neurosci
Khan F, Yaseen Shah S, Ahmad J, Al Mazroa A, Zahid A, Ilyas M, Abbasi QH, Shah SA.   +7 more
europepmc   +1 more source

Implementing ensemble of deep learning model with optimization techniques for human activity recognition to assist individuals with disabilities. [PDF]

Sci Rep
Alqahtani H.
europepmc   +1 more source

Enhancing human activity recognition with machine learning: insights from smartphone accelerometer and magnetometer data. [PDF]

PeerJ Comput Sci
Silva Zendron LA, Coelho PJ, Soares C, Pereira I, Pires IM.   +4 more
europepmc   +1 more source

A Comprehensive Methodological Survey of Human Activity Recognition Across Diverse Data Modalities. [PDF]

Sensors (Basel)
Shin J, Hassan N, Miah ASM, Nishimura S.
europepmc   +1 more source